Exclusive news, data and analytics for financial market professionals
Learn more about
Refinitiv
Skip to main content
Reuters home
World
Business
Markets
Sustainability
Legal
Breakingviews
Technology
Investigations
More
My View
Register
Company
Bluebird Bio Inc
Follow
24 results
Business
category
Bluebird bio submits US marketing application for blood disorder gene therapy
April 24, 2023
Business
category
Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group
April 12, 2023
Business
category
Sarepta slides as FDA about-turn on panel clouds gene therapy approval path
March 17, 2023
article with gallery
Healthcare & Pharmaceuticals
category
U.S. new drug price exceeds $200,000 median in 2022
January 5, 2023
Business
category
U.S. FDA lifts hold on Bluebird's sickle cell disease therapy
December 19, 2022
Future of Health
category
Sickle cell cure will be cost-effective if health disparities considered -study finds
December 15, 2022
Business
category
Australia's CSL prices hemophilia gene therapy at $3.5 million
November 22, 2022
Business
category
U.S. FDA approves bluebird bio's gene therapy for a rare neurological disorder
September 17, 2022
Business
category
Bluebird falls on worries over $2.8 mln gene therapy's commercial success
August 19, 2022
Future of Health
category
Bluebird's $2.8 million gene therapy becomes most expensive drug after U.S. approval
August 18, 2022
Future of Health
category
Bluebird bio's gene therapy for blood disorder gets FDA panel backing
June 10, 2022
World
category
Bluebird Bio's gene therapy for neurological disorder gets FDA panel backing
June 9, 2022
Future of Health
category
Bluebird bio's blood disorder therapy effective - FDA staff
June 7, 2022
Business
category
Bluebird bio to slash 30% of workforce as part of restructuring
April 5, 2022
Markets
category
Mosaic, Raytheon, Capri
March 7, 2022
Markets
category
U.S. RESEARCH ROUNDUP Akamai Technologies, Gitlab, RPM International
January 6, 2022
Markets
category
Insurance stocks, Zhihu, Cerner Corp, Robinhood
December 20, 2021
Business
category
Bluebird sickle cell gene therapy trial on partial hold amid investigation
December 20, 2021
Markets
category
Arena Pharma, Harley-Davidson, U.S. banks, travel stocks
December 13, 2021
Markets
category
Novavax, Harley-Davidson, Peloton, Arena Pharma
December 13, 2021
1 to 20 of 24